healthcare

Progyny, a leader in women’s health and family-building benefits, appointed Elizabeth Bierbower to its Board of Directors. This strategic move aims to leverage Bierbower’s three decades of healthcare experience, including leadership roles at Friday Health Plans and Humana, to support Progyny’s growth. The appointment reflects Progyny’s expansion plans and commitment to providing comprehensive solutions, focusing on improved outcomes and reduced costs.

Johnson & Johnson will release its second-quarter results on Wednesday, July 16th, at 8:30 AM Eastern Time. Led by CEO Joaquin Duato, the call will cover the company’s performance and strategy. Investors can access the webcast and presentation materials on J&J’s website, as well as dial-in for the call. Replays will also be available. The press release will be available that morning. The tentative date for the Q3 earnings call is October 14, 2025.